Skip to main content
. 2015 Oct 6;6(34):36172–36184. doi: 10.18632/oncotarget.5459

Table 3. Antibodies used in this study.

Antibody Animal source Dilution Pretreatment Vendor
OXPHOS Complex IV subunit COX 1 mouse monoclonal 1:1000 none Invitrogen Corporation
Hsp60 rabbit polyclonal 1:1000 none Abcam, ab46798, lot. GR51423
OXPHOS Complex V subunit ATP5B rabbit polyclonal 1:500 citrate puffer (pH 6.0) Sigma, AV48185, lot.QC18082
GAPDH mouse monoclonal 1:1000 citrate puffer (pH 6.0) Abcam, ab8245, lot.GR1883
OXPHOS Complex I subunit NDUF-S1 rabbit polyclonal 1:1000 none Sigma, N6039
p16INK4A surrogate marker for HPV-driven carcinogenesis mouse monoclonal 1:50 none BD Biosciences, clone G175–405
p53 mouse monoclonal 1:25 none BioLogo, clone DO-7